维护受试者在药物临床试验中的知情同意权  

Maintain the subjects′ informed consent in clinical trials of drugs

作　　者：杨慧艳[1] 

机构地区：[1]辽东学院医学院临床医学系,辽宁丹东118000

出　　处：《中国临床药理学杂志》2011年第11期886-887,共2页The Chinese Journal of Clinical Pharmacology

摘　　要：在药物临床试验中,要维护受试者的知情同意权。本文通过分析其意义及现状,提出了在药品实验过程中如何维护受试者知情同意权的措施,以便提高临床药物试验者的道德素养,并使保证药品临床试验在健康有序的环境中进行。To maintain the subjects′ informed consent in clinical trials of drugs.By analyzing the significance and the present situation of subjects′ informed consent,the writer puts forward the measures about how to maintain the subjects′ informed consent in the course of experimental drugs.The results of clinical drug trials is to improve subjects′ moral qualities.The conclusion is to ensure that the clinical trials of drugs can be underway in a healthy and orderly environment.

关 键 词：药物临床试验 受试者 知情同意权 

分 类 号：R954[医药卫生—药学]